Quantcast
Last updated on April 15, 2014 at 21:23 EDT

Latest pharmaceutical industry Stories

2014-04-14 12:34:19

DALLAS, April 14, 2014 /PRNewswire/ -- ReportsnReports.com offers Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases 2014 market research report in its store at http://www.reportsnreports.com/reports/280698-geriatric-medicine-development-carving-out-new-opportunities-to-treat-age-related-diseases.html . Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases report says despite the elderly...

2014-04-14 12:33:48

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, April 14, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Eli Lilly and Co. (NYSE: LLY), Medtronic Inc. (NYSE: MDT) and Alexion Pharmaceuticals Inc. (NASDAQ: ALXN). Private wealth members receive these notes ahead of publication. To reserve complementary...

2014-04-11 23:01:51

Transparency Market Research Report Added "Biosimilar And Follow-On Biologics Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018" to its database. Browse Full Report - http://www.transparencymarketresearch.com/biosimilar-and-follow-on-biologics-market.html. Albany, New York, USA (PRWEB) April 11, 2014 There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new...

2014-04-11 08:24:31

PITTSBURGH, April 11, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that a federal district court has granted its request to enforce a settlement agreement between Endo Pharmaceuticals and Mylan settling patent litigation in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Frovatriptan Succinate Tablets, 2.5 mg. This product is the generic version of FROVA(®), which is used to treat acute...

2014-04-11 08:24:24

HAYWARD, Calif., April 11, 2014 /PRNewswire/ -- Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), announced today the resubmission of Impax's New Drug Application (NDA) for RYTARY (IPX066) to the U.S. Food and Drug Administration (FDA). IPX066 is a patented extended- release capsule formulation of carbidopa and levodopa, an investigational drug for the symptomatic treatment of Parkinson's disease (PD). After discussions with the FDA, the Company has...

2014-04-11 08:24:12

ALBANY, New York, April 11, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Clinical Trial Management System Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019," the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Browse Global...

2014-04-11 08:22:40

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, April 11, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Eli Lilly & Co. (NYSE: LLY), UnitedHealth Group, Inc. (NYSE: UNH), Valeant Pharmaceuticals International, Inc. (NYSE: VRX), Forest Laboratories Inc. (NYSE: FRX), and Zoetis Inc. (NYSE: ZTS). Private wealth members receive these notes ahead of publication. To reserve complementary membership,...

2014-04-10 23:30:01

Verified Clinical Trials and ACRES form a strategic alliance to further the innovative systems-based solutions necessary to promote and facilitate research subject safety and improve data quality across the clinical trials industry. Verified Clinical Trials has pledged use of the research subject clinical trials database registry to stop dual enrollment in clinical trials to ACRES research sites. Cambridge, MA and Garden City, New York April 9, 2014 (PRWEB) April 10, 2014 Verified...

2014-04-10 23:00:56

Symposium to Highlight How Legislation in Europe and U.S. Can Help Bring Medicines to Market Washington (PRWEB) April 10, 2014 “Regulatory Challenges for Orphan Medicines,” a symposium that features presentations by a number of industry experts, will take place during the DIA 2014 50th Annual Meeting at the San Diego Convention Center from June 15 to 19. The symposium, held June 18 at 3:30 p.m., will focus on the regulatory environment and trends for orphan medicinal products around...

2014-04-10 16:24:30

INDIANAPOLIS, April 10, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the first quarter of 2014 on Thursday, April 24, 2014. Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial performance. The conference call will be held from 9:00 a.m. to 10:00 a.m. EDT. Investors, media and the general public can access a live webcast of the conference call...